Optimal radiotherapy dose scheduling with variable fraction sizes and breaks via sequential mixed-integer convex programming
Physics and Imaging in Radiation Oncology · 2026-05 · 39 · 101003
DOI: 10.1016/j.phro.2026.101003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Physics and Imaging in Radiation Oncology, 2026-05. Verfasst von Anqi Fu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Physics, Memorial Sloan-Kettering, 321 East 61st Street, 10065, NY, USA. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, National Institutes of Health, National Institutes of Health National Cancer Institute.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Physics, Memorial Sloan-Kettering, 321 East 61st Street, 10065, NY, USA.
- Department of Radiation Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, Netherlands.
Förderung
- NCI NIH HHS
- National Institutes of Health
- National Institutes of Health National Cancer Institute
Zitieren
APA
Fu, A., Gouw, Z., Jeong, J., & Deasy, J. O. (2026). Optimal radiotherapy dose scheduling with variable fraction sizes and breaks via sequential mixed-integer convex programming. Physics and Imaging in Radiation Oncology, 39, 101003. https://doi.org/10.1016/j.phro.2026.101003
Vancouver
Fu A, Gouw Z, Jeong J, Deasy JO. Optimal radiotherapy dose scheduling with variable fraction sizes and breaks via sequential mixed-integer convex programming. Physics and Imaging in Radiation Oncology. 2026;39:101003. doi:10.1016/j.phro.2026.101003
BibTeX
@article{Fu2026,
author = {Fu, Anqi and Gouw, Zeno and Jeong, Jeho and Deasy, Joseph O},
title = {Optimal radiotherapy dose scheduling with variable fraction sizes and breaks via sequential mixed-integer convex programming},
journal = {Physics and Imaging in Radiation Oncology},
year = {2026},
volume = {39},
pages = {101003},
doi = {10.1016/j.phro.2026.101003}
}
EUVIMED